2019 ACR/EULAR classification criteria and therapy in predicting organ damage accrual in patients with childhood-onset systemic lupus erythematosus: A …

N Kifer, M Sestan, M Frkovic, D Kifer, A Kozmar… - Lupus, 2022 - journals.sagepub.com
Objective We explored damage occurrence in patients with childhood-onset SLE (cSLE) and
aimed to predict the risk of organ damage occurrence in time. Methods The retrospective …

Analysis of 5-year hospitalization data of patients with systemic lupus erythematosus: Damage is a risk factor for frequent and longer stays

Ç Çetin, MG Can, S Öztaşkın, Y Yalçınkaya, A Gül… - Lupus, 2024 - journals.sagepub.com
Objective The annual hospitalization rate of patients with systemic lupus erythematosus
(SLE) is approximately 10%, and hospitalizations are responsible for most of the healthcare …

Risk factors for hospitalization in Mexican patients with systemic lupus erythematosus

IE García-Cañas, E Cuevas-Orta… - Lupus, 2024 - journals.sagepub.com
Introduction Systemic lupus erythematosus (SLE) is an autoimmune disease that often
requires hospitalization. Most hospitalizations are due to infections and/or disease activity …

The SLICC/ACR Damage Index (SDI) may predict adverse obstetric events in patients with systemic lupus erythematosus

MI Lacerda, GRR de Jesús, FC Dos Santos… - Lupus, 2021 - journals.sagepub.com
Objective The objective of this study was to evaluate the potential impact of irreversible
damage accrual in women with systemic lupus erythematosus (SLE) and adverse maternal …

Relevância das citocinas angiogênicas (VEGF e PlGF) e antiangiogênicas (sFlt-1) na assistência às pacientes grávidas com lúpus eritematoso sistêmico

N Ramires de Jesús - 2024 - bdtd.uerj.br
RESUMO RAMIRES DE JESÚS, Nilson. Relevância das citocinas angiogênicas (VEGF e
PlGF) e antiangiogênicas (sFlt-1) na assistência às pacientes grávidas com lúpus …

Readmissions of Systemic Lupus Erythematosus Patients: Analysis of the Nationwide Readmissions Database

J Potera - 2022 - search.proquest.com
Systemic lupus erythematosus (SLE) is a chronic, multifactorial autoimmune condition that
can affect virtually any organ and system in the body. The course of the disease is …

Micofenolato de Mofetilo en el tratamiento de inducción de la nefritis lúpica: Estudio de la vida real

M Moreno, R López, JMM Pérez - Reumatología al Día, 2022 - reumatologiaaldia.com
Objetivos: El objetivo principal fue evaluar la respuesta a 6 meses en el tratamiento de
inducción con MMF en NL moderada a severa. Métodos: Nosotros analizamos pacientes …